Special Issue "Lymphoma: From Molecular Biology to Targeted Therapy"
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 3865
Interests: Lymphoma, DNA damage repair, metabolomics, nuclear cytoplasmic molecular export
Interests: lymphoma (clinical and translational science); experimental therapeutics; DNA damage repair; nuclear cytoplasmic transport systems; biological; prognostic and therapeutic aspect of Waldenstrom macroglobulinemia; indolent and aggressive non-Hodgkin lymphoma
Interests: Waldenstrom Macroglobulinemia, Indolent Lymphomas, Multiple Myeloma, experimental therapeutics, biomarkers
We are pleased invite you to contribute your research to this Special Issue of Biomolecules. In this Issue, we aim to focus on exploring the current knowledge of the molecular pathways and mechanisms involved in the oncogenesis of Hodgkin and non-Hodgkin lymphoma, and to examine their role as potential therapeutic targets. Therefore, special emphasis will be given to the following important topics: 1) mechanisms associated with DNA synthesis, 2) prognostic and therapeutic implications of metabolomics/micronutrients, 3) nuclear-cytoplasmic molecular export and 4) any research focused on molecular biology and targeted therapy in Hodgkin and non-Hodgkin lymphoma.
We look forward to your original research pertaining to the abovementioned key topics in Hodgkin and non-Hodgkin lymphoma. Research conducted in preclinical, translational, retrospective, or prospective settings is welcome.
Dr. Thomas E. Witzig
Dr. Jithma Abeykoon
Dr. Saurabh Zanwar
Dr. Xavier Andrade-Gonzalez
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- New insights into the pathobiology of lymphoma;
- Genomic, epigenomic, transcriptomic and proteomic alterations in lymphoma;
- New mechanisms such as nucleocytoplasmic molecular export in lymphoma;
- Significance of metabolomics/micronutrients in lymphoma;
- Therapeutic significance of new targeted treatments in lymphoma.